A new study sheds light on the economic and clinical costs associated with "maintaining a failing T2DM treatment regimen."
Are you a US-based MD who sees patients with diabetes and likes to write? Why not blog for EndocrinologyNetwork.com? Be heard on topics that keep you up at night. Contact us here and we can send you the details.